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Dear Editor,
We have read with great interest the recently published
article titled, ‘‘The relationship between hyperuricemia and
the risk of contrast-induced nephropathy after percutaneous
coronary intervention in patients with relatively normal
serum creatinine’’, by Yong Liu et al. (1). In that well-
presented paper, the authors investigated the value of
hyperuricemia in predicting the risk of contrast-induced
nephropathy (CIN) in patients with relatively normal serum
creatinine who are undergoing CIN. They demonstrated
that CIN might develop in patients with normal creatinine
levels. Hyperuricemia is a significant and independent
predictor of CIN after percutaneous coronary intervention
(PCI) and results in significantly increased in-hospital
mortality and CIN incidence, which requires renal replace-
ment therapy after PCI. Thus, despite having normal
baseline creatinine levels, patients with hyperuricemia, an
intra-aortic balloon pump, emergent PCI, or older age
should receive more comprehensive renal prophylaxis to
reduce the occurrence of CIN.
CIN has been recognized as a serious complication of PCI
and may cause increased morbidity and mortality. CIN is
one of the most important reasons for hospital-acquired
renal failure and can cause prolonged hospitalization,
increased cost and incidence of renal and cardiovascular
events, and mortality. Elderly patients have a higher risk of
CIN because of decreased renal reserve. In addition, some
factors, such as an estimated glomerular filtration rate
(eGFR) of ,60 mL/min/1.73 m2, a left ventricular ejection
fraction ,45%, diabetes mellitus, hypotension, anemia,
emergency PCI, myocardial infarction history, and a
contrast agent dose .200 mL have been identified as risk
factors for CIN after PCI (2). Additionally, alcohol con-
sumption and the arterial blood pressure level before
contrast exposure may be associated with CIN.
Hypertriglyceridemia, metabolic syndrome, an impaired
fasting glucose level, and multivessel disease may also be
associated with a higher incidence of CIN (3). Some
medications, including renin-angiotensin-aldosterone sys-
tem medications, may also be related to CIN (4). It would
have been interesting for the authors to provide information
about these factors in this study.
Finally, the authors used the Cockcroft-Gault equation to
measure eGFR. The Cockcroft-Gault equation may under-
estimate eGFR in younger age groups and may overestimate
eGFR in older individuals compared with the Modification
of Diet in Renal Disease (MDRD) formula (5). Although the
Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) recently published an equation for eGFR using the
same variables (serum creatinine level, age, sex, and race) as
the MDRD formula, the CKD-EPI equation more accurately
categorized individuals with respect to long-term clinical
risk (6). In addition, even mild chronic kidney dysfunction,
defined as an eGFR ,90 mL/min, and dehydration were
risk factors for CIN. For this reason, it may be useful to
include the results using the CKD-EPI equation and
accounting for mild chronic kidney dysfunction and
dehydration as risk factors for CIN.
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